|
|
| ËéͧÊÁØ´ã¹»ÃÐà·Èä·Â | 5 |  | 2.92 |
| à¹ÁªÕÊ | 5 | | 2.92 |
| ÂÒ | 4 | | 2.34 |
| º·¤ÇÒÁ gmp ¹éíÒ´×èÁ | 4 | | 2.34 |
| ÊÒõ¡¤éÒ§ã¹à¹×éÍËÁÙ | 3 | | 1.75 |
| ÇÒ¿ÒÃÔ¹ | 3 | | 1.75 |
| Áҵðҹ gmp ¤ÙèÁ×Í ¾ÅÒÊà¨ÍÃìäëì | 3 | | 1.75 |
| ÈÙ¹Âì Í | 3 | | 1.75 |
| â«áÅÁ ¤×Í | 3 | | 1.75 |
| Ê¶ÔµÔ âç§Ò¹ÂÒ | 3 | | 1.75 |
| ¤ÙèÁ×ÍÍÒËÒûÅÍ´ÀÑ·ÕèÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ | 2 | | 1.17 |
| ¤ÙèÁ×Í ÍÒËÒûÅÍ´ÀÑ | 2 | | 1.17 |
| ¡ÒäǺ¤ØÁ »¯Ô¡ÔÃÔÂÒàÁÅÅÒÃì´ | 2 | | 1.17 |
| ¢èÒÇà¡ÕèÂǡѺÍÒËÒÃáÅÐÂÒ | 2 | | 1.17 |
| à¤Ã×èͧÁ×Íá¾·Âì ¹Òâ¹à·¤â¹âÅÂÕ | 2 | | 1.17 |
| à¤Ã×èͧÁ×ÍàྷÂì¹Òâ¹à·¤â¹âÅÂÕ | 2 | | 1.17 |
| ÍÒËÒÃáÅÐÂÒ | 2 | | 1.17 |
| swot ¡ÒúԹä·Â | 2 | | 1.17 |
| ÂÒʵÃÕà¾çÀÒ¤ ÊÃþ¤Ø³ | 2 | | 1.17 |
| http://mkpayap.payap.ac.th/course/myweb/nano/nano.htm | 2 | | 1.17 |
| ¡ÒâÖé¹·ÐàºÕ¹ Í | 2 | | 1.17 |
| ¤ÙèÁ×ÍÍÒËÒûÅÍ´ÀÑ | 2 | | 1.17 |
| ¤ÙèÁ×ÍÍÒËÒûÅÍ´ÀÑ | 2 | | 1.17 |
| warfarin card | 2 | | 1.17 |
| Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ | 2 | | 1.17 |
| 䫺ٷÃÒÁÕ¹ | 2 | | 1.17 |
| ¡ÒþԨÒóÒÊÔ¹¤éÒ¹Óà¢éÒ Í | 2 | | 1.17 |
| ˹ѧÊ×Í ¡Ó¨Ñ´àÁÕ¹éÍÂãËéÍÂÙèËÁÑ´ | 2 | | 1.17 |
| á¹Çâ¹éÁ¡ÒÃÃѺ·Ò¹ÂÒʵÃÕà¾çÀÒ¤ | 2 | | 1.17 |
| ¡ÒáÅѺªÒµÔÁÒà¡Ô´¢Í§ÅÒÁÐ | 2 | | 1.17 |
| ÂÒá¡éä¢éËÇÑ´ | 2 | | 1.17 |
| ¤Ó¢ÇÑ Í.Â.¹éÍ | 2 | | 1.17 |
| ÂÒ ors | 1 | | 0.58 |
| à·¤¹Ô¤¡ÒÃÊ׺¤é¹¢éÍÁÙÅ¡ÒÃÇԨѠ| 1 | | 0.58 |
| ¨Ò¡www.oryor.com | 1 | | 0.58 |
| ¡ÒèѴ·Óá¼¹ÂØ·¸ÈÒʵÃìÇԨѠ| 1 | | 0.58 |
| ÊÒÃ䫺ٷÃÒÁÕ¹ | 1 | | 0.58 |
| ÊÓÃǨ ÊíҹѡÇԷºÃÔ¡Òà | 1 | | 0.58 |
| ÂҢѺ¹éÓ¤ÒÇ»ÅÒ áÁèàÅ×è͹ | 1 | | 0.58 |
| ·Õ«Õ ÁÑ«Թ ÃÑ¡ÉÒ˹ͧã¹ã´éäËÁ | 1 | | 0.58 |
| lecithin ¤×Í | 1 | | 0.58 |
| «Ñ¤¤ÒÃÔ¹ | 1 | | 0.58 |
| swot¢Í§ºÃÔÉÑ·¡ÒúԹä·Â | 1 | | 0.58 |
| callnumber: Ǿ. ¡282¡ 2546 | 1 | | 0.58 |
| 6f ¤×ÍÍÐäà | 1 | | 0.58 |
| ¢èÒÇÊÒúÍáá«ì »¹à»×é͹ ÅÙ¡ªÔé¹ | 1 | | 0.58 |
| Êíҹѡ§Ò¹ÇԷºÃÔ¡Òà | 1 | | 0.58 |
| ¤Ùèá¢è§¢Í§ÂÒʵÃÕà¾çÀÒ¤ | 1 | | 0.58 |
| ÃÒ§ҹ ÇԨѠ¡ÒÃãªéÂҪش- ¾ÄµÔ¡ÃÃÁ¡ÒÃãªéÂҪش | 1 | | 0.58 |
| ¤ÇÊÁ¨ØÎÒÃì´´ÔÊ ÁÒäÁèµÃ§ | 1 | | 0.58 |
| ¾Ãº àÊ鹡ëÇÂàµÕëÂǢͧ Í | 1 | | 0.58 |
| ÁÒÃìªÍÒËÒÃáÅÐÂÒ | 1 | | 0.58 |
| ÂÒ naltrexone hcl | 1 | | 0.58 |
| á˹ÁµÃÒËÁÙªé͹·Í§ | 1 | | 0.58 |
| ÂÒãËÁè ¾Öè§Í¹ØÒµÔãªé 2554 | 1 | | 0.58 |
| àʾµÔ´ khat | 1 | | 0.58 |
| swot¡ÒúԹä·Â | 1 | | 0.58 |
| ÍÂ. ÊÕ¼ÊÁÍÒËÒà | 1 | | 0.58 |
| Êӹѡ§Ò¹ÇԷºÃÔ¡Òà | 1 | | 0.58 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 295 | 1 | | 0.58 |
| value chain analysis ¡ÒúԹä·Â | 1 | | 0.58 |
| ¢éͤÇÃÃÐÇѧ+ÂÒʵÃÕູâÅ | 1 | | 0.58 |
| ÊÒ¸ÒóÊØ¢ khat | 1 | | 0.58 |
| lÊÁÈÑ¡´Ôì ˹èͧ¾§Éì | 1 | | 0.58 |
| brilinta | 1 | | 0.58 |
| ¡ÒÃÇÔà¤ÃÒÐËì¡ÒúԹä·Â | 1 | | 0.58 |
| ¾ÒËйÓâää¢éËÇÑ´¹¡ | 1 | | 0.58 |
| ª×éÍ¢ÒÂ˹èÍäÁé | 1 | | 0.58 |
| ÇѤ«Õ¹ ¾ÔÉÊعѢºéÒ e ric | 1 | | 0.58 |
| «Ù¤ÃÒâÅÊ | 1 | | 0.58 |
| ÂÒàÅÔ¿âŪÑè¹ | 1 | | 0.58 |
| ¡Åä¡¡ÒÃÍÍ¡Ä·¸Ôì aspirin | 1 | | 0.58 |
| ÃÒª×èÍâç§Ò¹·ÓäÊé¡ÃÍ¡ | 1 | | 0.58 |
| ¾Ãº.¢éÍÁÙÅ¢èÒÇÊÒÃáÅСÒäØéÁ¤Ãͧ¼ÙéºÃÔâÀ¤ | 1 | | 0.58 |
| á͹µÔ·Í¡«Ô¹ | 1 | | 0.58 |
| Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ | 1 | | 0.58 |
| ÇÔà¤ÃÒÐ swot ¡ÒúԹä·Â | 1 | | 0.58 |
| ÃҤҪشµÃǨ ui kit | 1 | | 0.58 |
| ¼Å¡ÒôÓà¹Ô¹§Ò¹¹âºÒ 30 ºÒ·ÃÑ¡ÉÒ·Ø¡âä | 1 | | 0.58 |
| hyvet ÃÒÂÅÐàÍÕ´ | 1 | | 0.58 |
| ÂÒÅÐÅÒÂÅÔèÁàÅ×Í´ | 1 | | 0.58 |
| ¢éÍÁÙÅẺÊÓÃǨ¼§¡Ãͺã¹ÍÒËÒà | 1 | | 0.58 |
| ¤ÙèÁ×Í¡ÒõԴµÒÁÍÒ¡ÒÃäÁè¾Ö§»ÃÐʧ¤ì ¤ÇÒÁ¼Ô´»¡µÔ·Ò§Ãкº¼ÔÇ˹ѧ | 1 | | 0.58 |
| ÍÒ¡ÒÃá¾é ¤ÃÕÁ ¢ÁÔé¹Ê´ | 1 | | 0.58 |
| ma huang | 1 | | 0.58 |
| ethyl butylacetylaminopropionate ÍѹµÃÒ | 1 | | 0.58 |
| coloboma | 1 | | 0.58 |
| ¡Åä¡¡ÒÃÍÍ¡Ä·¸Ôì¢Í§ aspirin | 1 | | 0.58 |
| ÈÙ¹ÂìÇԷºÃÔ¡Òà | 1 | | 0.58 |
| ¡ÒâÖé¹·ÐàºÕ¹ à¤Ã×èͧÊÓÍÒ§ | 1 | | 0.58 |
| ¡ÅÙµéÒä¸â͹ ÂÒàʾµÔ´ | 1 | | 0.58 |
| ¡ÒüÅÔµÍÒËÒáÃлëͧ | 1 | | 0.58 |
| ẺÊٵõÓËÃѺáªÁ¾ÙÊÃмÁ¢Í§ÍÂ. | 1 | | 0.58 |
| ¡®ËÁÒÂÍ | 1 | | 0.58 |
| ¡Ô¹àÂÅÅÕè µÒ | 1 | | 0.58 |
| ¹Ó¢Í§Ãé͹äÊèÀÒª¹Ð | 1 | | 0.58 |
| ¤ÙèÁ×ÍÍÒËÒûÅÍ´ÀÑ·ÕèÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ | 1 | | 0.58 |
| inurl:/default.asp?content áÊ´§¤ÇÒÁ¤Ô´àËç¹ | 1 | | 0.58 |
| ÁÍ¡. 656-2529 | 1 | | 0.58 |
| ÂÒàʾµÔ´àÍÅàÍÊ´Õ | 1 | | 0.58 |
,
User's Guide
˹éÒÅçÍ¡ÍÔ¹| ʶԵÔÃÒ»Õ
| ʶԵÔÃÒÂà´×͹
| ʶԵÔÃÒÂÇѹ
| ʶԵÔÃÒªÑèÇâÁ§
| Eng
Pageview 
Unique IPs 
Sessions